People who inject drugs (PWID) face challenges in accessing whole-person health within the current health system landscape. This session will discuss how jurisdictions are implementing coordinated efforts to support PWID through syringe service programs (SSPs), Hepatitis C and STI testing, data-to-care models, and other support services. Additionally, this session will cover an update on safe consumption spaces and strategies to support this effort in the US.
Engaging with clients in the planning and delivery of healthcare services is a critical component for building relationships and achieving positive health outcomes. This session will discuss client engagement and cultural understanding as it relates to drug use, including utilizing community advisory boards, providing incentives, offering whole-person supportive programming, and promoting cultural awareness of clients.
Expanding access to substance use disorder treatment and support services is a priority for organizations serving PWID/PWUD. This session will cover the role of harm reduction, low-barrier support services, and HIV/HCV testing in comprehensive harm reduction programs. Presenters will discuss implementing routine HIV and HCV screening, integrating SUD screening in primary care, medication for opioid use disorder among reentry populations, and developing wraparound support services in syringe service programs.
COPYRIGHT © 2019-22 HEALTHHIV | ALL RIGHTS RESERVED.